TCL Archive O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology April 28, 1978
TCL Archive Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall September 15, 1978
TCL Archive User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations” January 20, 1989
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013